Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
The Role of Erlotinib an Epidermal Growth Factor Receptor (EGFR) Inhibitor in the Treatment of Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00570375. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00077116. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Cyclophosphamide, Fludarabine and Antithymocyte Globulin Conditioning in Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01255319. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hypomemylating Agents Combination With eDC Therapy for Elderly Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT04999943. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant
ClinicalTrials.gov study NCT02485535. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessment of Labile Plasma Iron (LPI) in Myelodysplastic Syndromes (MDS) and Primary Myelofibrosis
ClinicalTrials.gov study NCT01331603. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II Study of OPN-305 in Second-line Lower Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02363491. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Intensive Chemotherapy With or Without Volasertib in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02198482. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00459212. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00002800. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00004871. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00005598. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00700206. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Non-interventional Study of REVLIMID® (Lenalidomide) Treatment of IPSS Low- or Intermediate-1-risk Myelodysplastic Syndromes Associated With a Deletion 5q or Refractory/Relapsed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04036448. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT06196203. IPD Sharing: NO. Countries: 2. Publications: 0.
A Study of JNJ-74856665 in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT04609826. IPD Sharing: YES. Countries: 4. Publications: 0.
CIK-Cells in Relapsing Patients With Acute Leukemia or Myelodysplastic Syndromes After SCT.
ClinicalTrials.gov study NCT02752243. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase Ⅳ Study of Decitabine in Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02013102. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Feasibility Trial of Extracorporeal Iron Purification in Patients With Myelodysplastic Syndrome or Myelofibrosis
ClinicalTrials.gov study NCT06781099. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00003693. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.